Recent Updates
Recently added Catalysts

Ibuprofen caplet

Phase 3

Patient Compliance | Small molecule | Other |Pfizer, Inc.|Last Updated: May 30, 2016

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

UNCONTROLLED
Total Trials1
Total Enrollment738

FDA Designations

No designations recorded

Clinical trial landscape

Ibuprofen caplet · 1 trial · 1 indication

Phase 3 1
NCT02294019Actual Use Trial of Ibuprofen 400 mgPatient Compliance
COMPLETED738 Analytics
PHASE3COMPLETED
Actual Use Trial of Ibuprofen 400 mg
Patient ComplianceUnlock trial analytics

Study Endpoints

Primary Endpoints

Percentage of Participants Taking Greater Than (>) 1200 Milligram (mg) (>3 Caplets) on no More Than 2 Use Days During the Study
Day 1 up to 30 days

Percentage of participants whose behavior was either correct or acceptable were considered to be compliant. The behavior was considered correct if participants took more than 1200 mg (\>3 caplets) on either 0, 1 or 2 use days (where a use day was defined as a calendar day starting at 12:01 AM in which a participant received at least one dose of study medication), based on their diary. The behavior was considered acceptable if a participant exceeded the labelled daily dosing directions of taking more than 3 caplets per day, under the advice of a healthcare professional, based on information from the end of study follow-up interview.

Secondary Endpoints

Percentage of Participants Taking Greater Than (>) 400 mg (>1 Caplet) at a Time on no More Than 2 Dosing Occasions During the Study
Day1 up to 30 days
Unlock Study Endpoints

Study Design & Arms

MaskingNONE

Treatment Arms

ArmTypeDescription
Ibuprofen caplet armEXPERIMENTAL -

Interventions

NameTypeDescription
Ibuprofen 400 mg capletDRUG400 milligram (mg) caplet according to Drug Facts label
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites25

Inclusion Criteria: * Male or female at least 18 years of age (19 years of age in Alabama) * Subject reports taking over-the-counter (OTC) analgesics for pain or fever relief Exclusion Criteria: * Current government-issued identification (ID) * Pregnant or breastfeeding females

Countries:United States
Unlock Eligibility Criteria